Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 2
Submit an article Journal homepage
50
Views
7
CrossRef citations to date
0
Altmetric
Research Article

CD52 Expression in Mantle Cell Lymphoma

Adam J. Bass Duke University School of Medicine, Duke University Medical Center, Box 3961, Durham, NC 27710, USA
,
Jerald Gong Department of Pathology, Duke University Medical Center, Box 3712, Durham, NC 27710, USA
,
Ramona Nelson Department of Pathology, Duke University Medical Center, Box 3712, Durham, NC 27710, USA
&
David A. Rizzieri Division of Medical Oncology and Transplantation, Duke University Medical Center, Box 3961, Durham, NC 27710, USA
Pages 339-342 | Published online: 01 Jul 2009

  • Wiesenburger, D.D., Vose, J.M., Greiner, T.C. Lynch, J.C., Chan, W.C., Bierman, P.J., Dave. B.J., Sanger, W.G. and Armitage. J.O. (2000) "Mantle cell lymphoma: a clinicopathologic study of 68 cases from the Nebraska lymphoma study group". American Journal of Hematology 64, 190-196.
  • Lai, R. and Medeiros, J.L. (2000) "Pathologic diagnosis of mantle cell lymphoma". Clinical Lymphoma 1, 197-206.
  • Meusers, P. and Hense, J. (1999) "Management of mantle cell lymphoma". Annals of Hematology 78, 485-494.
  • Foran, J.M., Rohatiner, A.Z., Coiffier, B., Barbui, T., Johnson, S.A., Hiddemann. W., Radford, JA., Norton, A.J., Tollerfield. S.M., Wilson, M.P. and Lister. T.A. (1999) "Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma". Journal of Clinical Oncology 17, 546-553.
  • European Organization for the Research and Treatment of Cancer Lymphoma Cooperative GroupTeodorovic, I., Pittaluga, S., KluinNelemans, J., Meerwaidt. J., Hagenbeek, A., van Glabbeke, K., Somers. R., Bijnens, L., Noordijk, EM. and De Wolf Peeters, C. (1995) "Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes". Journal of Clinical Oncology 13, 2819-2826.
  • Inwards. D.J., Fonseca, R., Kurtin, P.J., Habermann. T.M., Knost. J., Hillman. D.W. and Witzig, T.E. (2000) "NCCTH Phase II trial of 2-chlorodeoxyadenostne (2-CDA) as therapy for previously treated mantle cell lymphoma: promising single agent activity limited by brief response", Blood 96, 598a.
  • Decaudin, D., Brousse. N., Brice, P., Haioun, C., Bourhis, J., Morel,P., Van Hoof, A., Souleau, B., Quesnel, B. and Gisselbrecht, C.(2000) "Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study". Bone Marrow Transplantation 25, 251-256.
  • Haas. R., Brittinger, G., Meusers. P., Murea, S., Goldschmidt. H.,Wannenmacher. M. and Hunstein. W. (1996) "Myeloablative Therapy with blood stem cell transplantation is effective in mantle cell lymphoma". Leukemia 10, 1975-1979.
  • Corrodini, P., Aslotfi, M., Cherasco. C., Ladetto, M., Voena, C.,Caracciolo. D., Pileri. A. and Tarella, C. (1997) "Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high dose chemotherapy and peripheral blood progenitor cell autografting", Blood 89,724-731.
  • Vandenberghe, E., Ruiz de Elvira, C., lsaacson, P., Lopez-Guillermo, A., Conde, E., Gisselbrecht, C., Guilhot, F., Schmitz,N. and Goldstone, A. (2000) "Does transplantation improve Outcome in mantle cell lymphoma". Blood 96. 2072a.
  • Weisenburger, D.D. and Armitage, J.O. (1996) "Mantle cell lymphoma-an entity comes of age". Blood 87,4483-4494.
  • Bindon, C.l., Hale, G. and Waldmann. H. (1988) "Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies". European Journal of Immunology 18, 1507-1514.
  • Dyer, M.J.S. (1999) "The role of CAMPATH-IH antibodies in the treatment of lymphoid malignancies". Seminars in Oncology 26,52 -57.
  • Hale. G., Xia, M.Q., Tighe, H.P., Dyer. M.J. and Waldmann, H. (1990) "The CAMPATH-IH antigen (CDw52)". Tissue Antigens 35. 118-127.
  • [I5] Bentz, M., Plesch, A., Bullinger, L., Stilgenbauer. S., Ott. G., Muller-Hermelink, H.K., Baudis, M., Barth, T.F., Moller. P., Lichter. P. and Dohner, H. (2000) "t(11:14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphoeytic leukemia", Genes, Chromosomes and Cancer 27, 285-294.
  • Harris, N.L. Jaffe, E.S., Stein. H., Banks. P.M., Chan. J.K., Cleary, M.L. Delsol. G., De Wolf-Peeters. C., Falini, B. and Gatter. K.C. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group". Blood 84. 1361 - 1392.
  • Yatabe. Y., Suzuki. R., Tobinai. K., Matsuno. Y., Ichinohasama. R., Okamoto, M., Yamaguchi. M., Tamaru. J., Uike, N., Hashimoto. Y., Morishima, Y., Suchi, T., Seto, M. and Nakamura, S. (2000) "Significance of cyclin Dl overexpression for the diagnosis of mantle cell lymphoma: a clininicopathologic comparison of cyclin Dl- positive MCL and cyclin Dl-negative MCL-like B-cell lymphoma", Blood 95, 2253-2261.
  • Salisbury, J.R., Raspon. N.T., Codd. J.D., Rogers. M.V. and Nethersell, A.B. (1994) "Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas", Journal of Clinical Pathology 47. 313-317.
  • Osterborg. A., Dyer. M.J., Bunjes. D, Pangalis. G.A., Bastion, Y., Catovsky, D. and Mellstedt. H. (1997) "Phase II multicenter study of human CD52 antibody in previously treated chronic lymphoeytic leukemia". Journal of Clinical Oncology 15, 1567-1574.
  • Osterborg, A., Fassas. A.S., Anagnostopoulos. A., Dyer. MJ., Catovsky. D. and Mellstedt, H. (1996) "Humanized CD52 monoclonal antibody CAMPATH-IH as first-line treatment in chronic lymphoeytic leukaemia". British Journal of Haematalogy 93.151-153.
  • Lundin. J., Osterborg, A., Brittinger, G., Crowther, D. Dombret. H., Engert. A., Epenetos. A., Gisselbrecht. C., Huhn, D., Jaeger, U.,Thomas, J., Marcus, R., Nissen, N., Poynton, C., Rankin. E., Stahel, R., Uppenkamp. M., Willemze. R. and Mellstedt, H. (1998) "CAMPATH-IH monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's Iymphomas: a phase II multicenter study". Journal of Clinical Oncology 16, 3257 3263.
  • Rai, K.R. (1999) "New biologic therapies". Seminars in Hematology 5(Suppl.5), SI2-SI7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.